Menzies, A. M., Salman, P., Frontera, O. A., Pook, D., Hocking, C. M., Zakharia, Y., . . . Amin, A. (2025). Administration of nivolumab plus ipilimumab: Infusion of the fixed-ratio combination versus sequential infusions in two randomized controlled trials of metastatic melanoma (CheckMate 742) and renal cell carcinoma (CheckMate 800).
Citación estilo ChicagoMenzies, Alexander M., et al. Administration of Nivolumab Plus Ipilimumab: Infusion of the Fixed-ratio Combination Versus Sequential Infusions in Two Randomized Controlled Trials of Metastatic Melanoma (CheckMate 742) and Renal Cell Carcinoma (CheckMate 800). 2025.
Cita MLAMenzies, Alexander M., et al. Administration of Nivolumab Plus Ipilimumab: Infusion of the Fixed-ratio Combination Versus Sequential Infusions in Two Randomized Controlled Trials of Metastatic Melanoma (CheckMate 742) and Renal Cell Carcinoma (CheckMate 800). 2025.